The role of imidazole and benzimidazole heterocycles in Chagas disease: A review

I Beltran-Hortelano, V Alcolea, M Font… - European journal of …, 2020 - Elsevier
The haemoflagellate protozoan Trypanosoma cruzi (T. cruzi) is the causative agent of
Chagas disease (CD), a potentially life-threatening disease. Little by little, remarkable …

[HTML][HTML] Examination of multiple Trypanosoma cruzi targets in a new drug discovery approach for Chagas disease

I Beltran-Hortelano, V Alcolea, M Font… - Bioorganic & medicinal …, 2022 - Elsevier
Chagas disease (CD) is a centenarian neglected parasitosis caused by the protozoan
Trypanosoma cruzi (T. cruzi). Despite the continuous efforts of many organizations and …

Antioxidant defence system as a rational target for Chagas disease and Leishmaniasis chemotherapy

AMM Santi, SMF Murta - Memórias do Instituto Oswaldo Cruz, 2022 - SciELO Brasil
Chagas disease and leishmaniasis are neglected tropical diseases caused by the
protozoan parasites Trypanosoma cruzi and Leishmania spp., respectively. They are among …

[PDF][PDF] It is important to compute intramolecular hydrogen bonding in drug design

MJR Yunta - Am. J. Model. Optim, 2017 - researchgate.net
The effect of weak intermolecular interactions on the binding affinity between ligand-protein
complexes plays an important role in stabilizing a ligand at the interface of a protein …

An insight into the medicinal perspective of synthetic analogs of imidazole

S Rulhania, S Kumar, B Nehra, GD Gupta… - Journal of molecular …, 2021 - Elsevier
Imidazole remains a privileged heterocycle in drug discovery. Imidazole scaffold is a
ubiquitous motif that is present in several pharmacologically important drug molecules such …

Current and future prospects of nitro-compounds as drugs for trypanosomiasis and leishmaniasis

S Patterson, AH Fairlamb - Current Medicinal Chemistry, 2019 - ingentaconnect.com
Interest in nitroheterocyclic drugs for the treatment of infectious diseases has undergone a
resurgence in recent years. Here we review the current status of monocyclic and bicyclic …

Trypanothione reductase and superoxide dismutase as current drug targets for Trypanosoma cruzi: an overview of compounds with activity against Chagas disease

I Beltran-Hortelano, S Perez-Silanes… - Current Medicinal …, 2017 - ingentaconnect.com
It has been over a century since Carlos Chagas discovered the Trypanosoma cruzi (T. cruzi)
as the causative agent of Chagas disease (CD), a neglected tropical disease with several …

Nitro compounds against trypanosomatidae parasites: Heroes or villains?

PF da Silva Santos-Júnior, LR Silva… - Bioorganic & Medicinal …, 2022 - Elsevier
Abstract Chagas disease and Human African trypanosomiasis (HAT) are caused by
Trypanosoma cruzi, T. brucei rhodesiense or T. b. gambiense parasites, respectively; while …

Recent advances in the synthesis of biologically active cinnoline, phthalazine and quinoxaline derivatives

Y Taek Han, JW Jung, NJ Kim - Current Organic Chemistry, 2017 - ingentaconnect.com
In the recent decades, N-heterocycles are widely used as versatile scaffolds for the
development of biologically active compounds and considered as one of the privileged …

Role of pharmacological active phthalazine scaffolds in medicinal chemistry

SMN Sakib - Open Science Foundation, 2023 - osf.io
Phthalazine derivatives have recently received a lot of interest in the realm of physiologically
active chemical research. Introduce this phthalazine moiety to a researcher in a new …